Aubrey Capital Management LTD Neurocrine Biosciences Inc Transaction History
Aubrey Capital Management LTD
- $285 Million
- Q3 2025
A detailed history of Aubrey Capital Management LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Aubrey Capital Management LTD holds 3,719 shares of NBIX stock, worth $527,949. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,719Holding current value
$527,949% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
687Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.01 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.39 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$790 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$634 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$438 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...